Panagora Asset Management Inc Allogene Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

  • $20.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$6.78 - $12.28 $426,923 - $773,247
-62,968 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$7.65 - $15.29 $551,725 - $1.1 Million
-72,121 Reduced 53.39%
62,968 $574,000
Q4 2021

Feb 10, 2022
BUY
$13.13 - $24.52 $1.38 Million - $2.57 Million
104,825 Added 346.37%
135,089 $2.02 Million
Q2 2021

Aug 11, 2021
BUY
$23.49 - $35.8 $710,901 - $1.08 Million
30,264 New
30,264 $789,000

Others Institutions Holding ALLO

# of Institutions
163
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $302M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email